163 related articles for article (PubMed ID: 37081846)
1. High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis.
Fang YW; Wang JT; Lin TY; Lee CJ; Jang TN; Tsai MH; Liou HH
Front Med (Lausanne); 2023; 10():1098871. PubMed ID: 37081846
[TBL] [Abstract][Full Text] [Related]
2. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
[TBL] [Abstract][Full Text] [Related]
3. Meta-Analysis of the Association between Fibroblast Growth Factor 23 and Mortality and Cardiovascular Events in Hemodialysis Patients.
Gao S; Xu J; Zhang S; Jin J
Blood Purif; 2019; 47 Suppl 1(Suppl 1):24-30. PubMed ID: 30699419
[TBL] [Abstract][Full Text] [Related]
4. Phosphate control in reducing FGF23 levels in hemodialysis patients.
Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
[TBL] [Abstract][Full Text] [Related]
5. The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans.
Bielesz B; Reiter T; Hammerle FP; Winnicki W; Bojic M; Gleiss A; Kieweg H; Ratzinger F; Sunder-Plassmann G; Marculescu R
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32823844
[TBL] [Abstract][Full Text] [Related]
6. C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival.
Chu C; Elitok S; Zeng S; Xiong Y; Hocher CF; Hasan AA; Krämer BK; Hocher B
BMC Nephrol; 2021 Apr; 22(1):125. PubMed ID: 33832449
[TBL] [Abstract][Full Text] [Related]
7. Renal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans.
Sharma S; Katz R; Ginsberg C; Bullen A; Vallon V; Thomson S; Moe OW; Hoofnagle AN; de Leeuw PW; Kroon AA; Houben AJHM; Ix JH
J Bone Miner Res; 2022 Jun; 37(6):1170-1178. PubMed ID: 35373859
[TBL] [Abstract][Full Text] [Related]
8. Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients.
Lee WT; Fang YW; Chen M; Liou HH; Lee CJ; Tsai MH
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836085
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
Hanudel MR; Wesseling-Perry K; Gales B; Ramos G; Campbell V; Ethridge K; Scotti M; Elashoff DA; Alejos J; Reemtsen B; Salusky IB
Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
[TBL] [Abstract][Full Text] [Related]
10. C-terminal fragment of fibroblast growth factor 23 improves heart function in murine models of high intact fibroblast growth factor 23.
Hu MC; Reneau JA; Shi M; Takahashi M; Chen G; Mohammadi M; Moe OW
Am J Physiol Renal Physiol; 2024 Apr; 326(4):F584-F599. PubMed ID: 38299214
[TBL] [Abstract][Full Text] [Related]
11. Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism.
Fořtová M; Hanousková L; Valkus M; Čepová J; Průša R; Kotaška K
Endocr Connect; 2022 Jan; 11(1):. PubMed ID: 34860179
[TBL] [Abstract][Full Text] [Related]
12. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
Emrich IE; Brandenburg V; Sellier AB; Schauerte J; Wiedenroth J; Untersteller K; Lennartz CS; Seiler-Mussler S; Wagenpfeil S; Fliser D; Heine GH
Am J Nephrol; 2019; 49(3):203-211. PubMed ID: 30808827
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.
Paul S; Wong M; Akhabue E; Mehta RC; Kramer H; Isakova T; Carnethon MR; Wolf M; Gutiérrez OM
J Am Heart Assoc; 2021 Aug; 10(16):e020196. PubMed ID: 34387090
[TBL] [Abstract][Full Text] [Related]
14. Biological variability of plasma intact and C-terminal FGF23 measurements.
Smith ER; Cai MM; McMahon LP; Holt SG
J Clin Endocrinol Metab; 2012 Sep; 97(9):3357-65. PubMed ID: 22689697
[TBL] [Abstract][Full Text] [Related]
15. Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia.
van Vuren AJ; Eisenga MF; van Straaten S; Glenthøj A; Gaillard CAJM; Bakker SJL; de Borst MH; van Wijk R; van Beers EJ
Blood Adv; 2020 Apr; 4(8):1678-1682. PubMed ID: 32324886
[TBL] [Abstract][Full Text] [Related]
16. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
Bożentowicz-Wikarek M; Kocełak P; Owczarek A; Olszanecka-Glinianowicz M; Mossakowska M; Skalska A; Więcek A; Chudek J
Clin Biochem; 2015 Apr; 48(6):431-6. PubMed ID: 25583093
[TBL] [Abstract][Full Text] [Related]
17. Saccharated ferric oxide attenuates haematopoietic response induced by epoetin beta pegol in patients undergoing haemodialysis.
Iwasaki T; Fujimori A; Nakanishi T; Okada S; Hanawa N; Hasuike Y; Kuragano T
BMC Nephrol; 2021 Apr; 22(1):124. PubMed ID: 33832448
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
[TBL] [Abstract][Full Text] [Related]
19. Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patients.
Egli-Spichtig D; Hamid AK; Arroyo EMP; Ketteler M; Wiecek A; Rosenkranz AR; Pasch A; Lorenz H; Hellmann B; Karus M; Ammer R; Rubio-Aliaga I; Wagner CA
Clin Kidney J; 2023 Oct; 16(10):1622-1633. PubMed ID: 37779856
[TBL] [Abstract][Full Text] [Related]
20. C-Terminal Fibroblast Growth Factor 23, Iron Deficiency, and Mortality in Renal Transplant Recipients.
Eisenga MF; van Londen M; Leaf DE; Nolte IM; Navis G; Bakker SJL; de Borst MH; Gaillard CAJM
J Am Soc Nephrol; 2017 Dec; 28(12):3639-3646. PubMed ID: 28774998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
